Cargando…

Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)

INTRODUCTION: Teneligliptin is an antidiabetic medication that has been approved for the management of type 2 diabetes mellitus (T2DM) in Japan, South Korea and India. It is one of the most commonly prescribed antihyperglycaemic agents. The aim of this study was to assess the effectiveness of teneli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Sujoy, Tiwaskar, Mangesh, Chawla, Rajiv, Jaggi, Shalini, Asirvatham, Arthur, Panikar, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509012/ https://www.ncbi.nlm.nih.gov/pubmed/32779100 http://dx.doi.org/10.1007/s13300-020-00880-4

Ejemplares similares

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
por: Ghosh, Sujoy, et al.
Publicado: (2016)

Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective
por: Viswanathan, Vijay, et al.
Publicado: (2019)

Teneligliptin in management of type 2 diabetes mellitus
por: Sharma, Surendra Kumar, et al.
Publicado: (2016)

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2022)

Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
por: Seo, Da Hea, et al.
Publicado: (2021)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Efficacy and safety of teneligliptin
por: Singh, Awadhesh Kumar
Publicado: (2017)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
por: Joshi, Shilpa, et al.
Publicado: (2023)

Endocrinology training in India
por: Bajaj, Sarita, et al.
Publicado: (2015)

Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study
por: Borgharkar, Surendra S, et al.
Publicado: (2019)

Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
por: Kalra, Sanjay, et al.
Publicado: (2023)

Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India
por: Sabharwal, Mudit, et al.
Publicado: (2022)

Knowledge, Attitude, and Practice on Cervical Cancer and Screening Among Women in India: A Review
por: Taneja, Neha, et al.
Publicado: (2021)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2020)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
por: Kishimoto, Miyako
Publicado: (2013)

Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2019)

Conducting real-world evidence studies in India
por: Bhatt, Arun
Publicado: (2019)

Indian Phenotype Characteristics Among Patients with Type 2 Diabetes Mellitus: Insights from a Non-interventional Nationwide Registry in India
por: Kalra, Sanjay, et al.
Publicado: (2022)

One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus
por: Das, Ashok K., et al.
Publicado: (2021)

Teneligliptin and “Thorough QTc study”: thorough enough?
por: Ghosal, Samit
Publicado: (2019)

Prevalence of Cognitive Decline in Type 2 Diabetes Mellitus Patients: A Real-World Cross-Sectional Study in Mysuru, India
por: Kinattingal, Nabeel, et al.
Publicado: (2023)

Intraocular Pressure and Its Determinants in Subjects With Type 2 Diabetes Mellitus in India
por: Biswas, Sayantan, et al.
Publicado: (2011)

Clinical Utility of a Digital Therapeutic Intervention in Indian Patients With Type 2 Diabetes Mellitus: 12-Week Prospective Single-Arm Intervention Study
por: Chawla, Rajeev, et al.
Publicado: (2022)

Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study
por: Agarwal, Piyush, et al.
Publicado: (2018)

Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Xiaoxuan, et al.
Publicado: (2018)

Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study
por: Fushimi, Yoshiro, et al.
Publicado: (2020)

Response to “Health economics in India: The case of diabetes mellitus”
por: Gupta, Yashdeep, et al.
Publicado: (2014)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Glargine-300: An updated literature review on randomized controlled trials and real-world studies
por: Ghosh, Sujoy, et al.
Publicado: (2020)

Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance
por: Haneda, Masakazu, et al.
Publicado: (2018)

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
por: Tandon, Tanya, et al.
Publicado: (2019)

Teneligliptin-induced hair loss: A case report
por: Agrawal, Prabhat K., et al.
Publicado: (2020)

Exanthematous Drug Eruption as a Side Effect of Teneligliptin
por: Sunil, Krupa A., et al.
Publicado: (2021)

Hypoglycemia at the time of Covid-19 pandemic
por: Shah, Kiran, et al.
Publicado: (2020)

Baseline characteristics of participants in the LANDMARC trial: A 3‐year, pan‐india, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus
por: Das, Ashok K., et al.
Publicado: (2021)

Quantifying Remission Probability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2021)

Teneligliptin As an Initial Therapy for Newly Diagnosed, Drug Naive Subjects With Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2014)

Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy
por: Kumar, Amit, et al.
Publicado: (2019)

Management of periodontal disease in patients with diabetes- good clinical practice guidelines: A joint statement by Indian Society of Periodontology and Research Society for the Study of Diabetes in India
por: Jain, Ashish, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e918u0unpf9ais1qiclir6n18a